Phase 3 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who understand the purpose and risks of the study and have given their formal written consent to participate
- People who are male and between 19 and 65 years old at the time of signing the consent form
- People who have a confirmed diagnosis of hemophilia A, based on their medical history and laboratory test results
- People who have previously used Factor VIII (FVIII) products for at least 150 treatment days before joining the study
- People who have no prior history of developing inhibitors (antibodies that block) Factor VIII
- People who agree to use a reliable barrier method of contraception from the time of signing the consent form
- People who are willing and able to attend scheduled visits and follow the study procedures as planned
Who may not be able to join:
- People who have a bleeding disorder that is not related to hemophilia A
- People whose liver function tests came back abnormal during the screening period
- People whose general laboratory test results were abnormal during the screening period
- People who have an active or long-term hepatitis B or hepatitis C infection, or who are currently receiving antiviral treatment for hepatitis B or C
- People who have an active disease affecting the immune system throughout the body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613817454595
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Annualized Bleeding Rate (ABR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.